Feb 03, 2016 13:30 pm UTC| Business
HORSHAM, Pa., Feb. 3, 2016 -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, will broadcast live on its website, www.tollbrothers.com, a conference call to discuss its FY 2016 first quarter...
Metso's Nomination Board's proposal for the composition and remuneration of the Board of Directors
Feb 03, 2016 13:22 pm UTC| Business
HELSINKI, Finland, Feb. 3, 2016 -- Proposal on the composition of Board of Directors Metso Corporation's Nomination Board proposes to the next Annual General Meeting, which will be held on March 21, 2016, that the...
Feb 03, 2016 13:15 pm UTC| Business
CHICAGO, Feb. 03, 2016 -- Epazz, Inc. (OTCPINK:EPAZ), a leading provider of cloud-based business software solutions, announced today that it has reported positive Net Income of $162,183, compared to negative Net Income...
Advaxis’ Axalimogene Filolisbac to be Developed and Commercialized in Latin America With Stendhal
Feb 03, 2016 13:05 pm UTC| Business
PRINCETON, N.J., Feb. 03, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that it has entered into a co-development and commercialization...
TESARO to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Feb 03, 2016 13:05 pm UTC| Business
WALTHAM, Mass., Feb. 03, 2016 -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, President and COO of TESARO, will present at the Leerink Partners 5th Annual Global...
MaritzCX Delivers Breakthrough Process to Grow Revenue through Customer Experience
Feb 03, 2016 13:05 pm UTC| Business
SALT LAKE CITY, Feb. 3, 2016 -- With the launch of CXEvolution™, MaritzCX has cracked the code on translating customer experience (CX) programs into hard business results. CXEvolution is the first and most...
Bellerophon to Participate in LEERINK Partners 5th Annual Global Healthcare Conference
Feb 03, 2016 13:03 pm UTC| Business
WARREN, N.J., Feb. 03, 2016 -- Bellerophon Therapeutics,Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will participate in LEERINK Partners 5th Annual Global Healthcare...